Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Fermenta Biotech Ltd.

NSE: 506414 | BSE:506414

₹206.30 23.75 (13.01%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

187.00

Today’s High

219.00

52W low

133.00

52W High

219.00

Open Price

190.90

Prev. Close

158.7500

Volume

436687.00

Value

90088528.10

Fundamentals

Market Cap

607.20

Price to Earnings

-26.50

Price to Book Value

2.10

Dividend Yield

0.60

PE to Growth

-0.50

Op Revenue TTM

335.66

Net Profit TTM

-22.88

Cash From Operating Activity

105.35

Return on Equity %

-8.31

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

184.1

10Day EMA

177.1

12Day EMA

175.6

20Day EMA

172

26Day EMA

170.5

50Day EMA

168.1

100Day EMA

166.7

200Day EMA

165.1

5Day SMA

178.6

10Day SMA

173.4

20Day SMA

170.9

30Day SMA

166.6

50Day SMA

166.2

100Day SMA

168.6

150Day SMA

165.8

200Day SMA

165.6

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

54

Week

61.7

Month

69.1

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

204.12

PIVOT

First Resistance

221.23

Second Resistance

236.17

Third Resistance

253.28

First Support

189.18

Second Support

172.07

Third Support

157.13

Relative Strength Index

79.39

Money Flow Index

81.95

MACD

5.14

MACD Signal

2.3

Average True Range

9.73

Average Directional Index

17.01

Rate of Change (21)

34

Rate of Change (125)

13.2

Commodity Channel Index

412.7

Williams %R

-22.8

BETA

1 Month

0.26

3 Month

0.75

1 Year

0.79

3 Year

0.33

PRICE CHANGE ANALYSIS

↑ 24.28%

1 Week

Low

High

163

219.05

↑ 29.95%

1 Month

Low

High

157

219.05

↑ 22.76%

3 Months

Low

High

145

219.05

↑ 16.19%

6 Months

Low

High

145

219.05

↑ 50.8%

1 Year

Low

High

133

219.05

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 91.15 91.93 53.33 78.83 101.66 53.75 92.72 88.35 97.63 86.54 101.36
Operating Expenses Qtr 80.73 62.86 62.93 63.59 75.01 59.82 78.86 76.43 76.11 73.13 81.47
Operating Profit Qtr 8.92 26.49 -11.62 13.19 25.57 -6.07 11.26 8.03 18.55 12.27 17.54
EBIDT Qtr Cr 10.42 29.07 -18.59 15.24 11.64 -50.66 13.85 11.93 21.52 13.40 19.90
Depreciation Qtr 6.20 6.13 5.68 5.69 5.89 6.16 6.26 6.20 6.03 6.21 5.97
Net Profit Qtr -7.25 11.70 -27.98 4.79 -1.77 -58.95 2.13 1.05 9.07 1.82 6.57
Basic EPS Qtr -2.51 4.05 -9.69 1.66 -0.61 -20.44 0.74 0.37 3.14 0.63 2.28
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 315.24 336.48 395.49 379.44 312.82
Operating Expenses Annual Cr 270.10 290.12 312.02 279.10 231.01
Operating Profit Annual 36.99 38.80 75.94 93.72 69.49
Operating Profit Margin Annual % 11.73 11.53 19.20 24.70 22.21
Total Expenses Annual Cr 310.85 335.58 352.92 316.21 265.27
EBIDT Annual Cr 45.14 46.36 83.46 100.34 81.81
EBIDT Annual margin % 14.32 13.78 21.10 26.44 26.15
Depreciation 23.70 24.51 23.67 19.03 14.94
PAT Before ExtraOrdinary Items Annual Cr -18.74 -57.53 30.24 51.97 63.67
Net Profit Annual -18.74 -57.53 30.24 51.97 63.67
Basic EPS Annual -6.49 -19.94 10.48 18.02 22.07
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 314.23 334.07 395.97 370.45 312.60
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 89.46 116.89 130.02 119.24 111.50
Total Current Liabilities Annual Cr 160.89 213.69 186.66 192.85 185.51
Total Capital Plus Liabilities Annual Cr 564.58 664.66 712.65 682.54 609.61
Fixed Assets Annual 252.99 303.07 321.33 306.48 267.58
Total Non Current Assets Annual 326.35 411.41 397.40 374.58 327.15
Total Current Assets Annual 238.23 253.25 315.25 307.96 282.46
Total Assets Annual 564.58 664.66 712.65 682.54 609.61
Contingent Liabilities plus Commitments Annual Cr - 30.65 29.37 12.79 25.32
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 105.02 124.46 50.41 62.96 29.83
Cash from Investing Activity Annual -15.15 -64.44 -32.46 -43.61 -39.19
Cash from Financing Annual Activity -90.86 -40.80 -21.76 -1.32 -47.63
Net Cash Flow Annual - 19.22 -3.81 18.03 -56.99
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 108.83 115.77 137.26 128.42 108.36
ROE Annual % -5.96 -17.22 7.63 14.02 20.36
ROCE Annual % 5.31 4.84 11.36 16.60 15.76
Total Debt to Total Equity Annual 0.42 0.65 0.60 0.56 0.66
EBDIT Annual Margin % 14.69 14.09 21.51 26.91 27.22
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 102.11 101.49 58.80 84.45 106.32 54.86 100.72 95.73 99.04 94.03 102.12
Operating Expenses Qtr 91.36 73.85 70.82 71.51 85.65 64.69 94.71 86.95 78.39 90.65 84.14
Operating Profit Qtr 5.98 25.12 -13.92 10.94 19.51 -9.83 3.32 4.94 17.77 2.21 15.70
EBIDT Qtr Cr 10.76 27.64 -19.45 12.94 11.60 -29.23 6.01 8.78 20.65 3.37 17.98
Depreciation Qtr 6.46 6.38 5.93 5.95 6.19 6.32 9.07 6.67 6.49 6.68 6.44
Net Profit Qtr -7.14 9.85 -27.80 2.21 -4.93 -37.65 -8.05 -2.31 7.72 -8.34 4.14
Basic EPS Qtr -2.41 3.41 -9.63 0.64 -1.30 -12.97 -2.79 -0.80 2.66 -2.79 1.56
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 346.86 357.64 406.65 385.54 305.27
Operating Expenses Annual Cr 307.55 332.00 337.06 295.63 227.71
Operating Profit Annual 28.12 17.94 61.45 81.66 65.24
Operating Profit Margin Annual % 8.11 5.02 15.11 21.18 21.37
Total Expenses Annual Cr 349.31 381.03 379.71 333.91 261.85
EBIDT Annual Cr 39.32 25.63 69.59 89.91 77.56
EBIDT Annual margin % 11.34 7.17 17.11 23.32 25.41
Depreciation 24.72 28.25 25.56 20.31 15.00
PAT Before ExtraOrdinary Items Annual Cr -24.01 -53.55 15.06 42.53 59.52
Net Profit Annual -24.01 -51.50 15.45 45.51 59.53
Basic EPS Annual -7.99 -17.85 5.33 15.69 20.63
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 288.86 314.63 372.13 360.59 309.44
Minority Interest Liability Annual Cr -3.70 -2.75 -0.68 -0.30 0.01
Total Non Current Liabilities Annual Cr 89.41 115.23 128.27 117.45 109.63
Total Current Liabilities Annual Cr 173.26 208.69 207.12 209.33 194.60
Total Capital Plus Liabilities Annual Cr 547.83 635.81 706.84 687.08 613.67
Fixed Assets Annual 250.60 300.45 322.20 309.12 266.79
Total Non Current Assets Annual 306.08 382.83 392.82 377.45 329.66
Total Current Assets Annual 241.75 252.97 314.02 309.62 284.01
Total Assets Annual 547.83 635.81 706.84 687.08 613.67
Contingent Liabilities plus Commitments Annual Cr - 27.64 26.35 9.78 22.41
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 105.35 116.70 43.44 62.60 34.46
Cash from Investing Activity Annual -15.50 -56.32 -26.04 -41.55 -43.66
Cash from Financing Annual Activity -90.85 -40.79 -21.58 -1.14 -47.45
Net Cash Flow Annual - 19.59 -4.17 19.90 -56.65
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 98.76 108.08 128.76 124.90 107.27
ROE Annual % -8.31 -16.36 4.15 12.62 19.23
ROCE Annual % 3.89 -0.61 8.81 14.56 14.92
Total Debt to Total Equity Annual 0.46 0.69 0.63 0.57 0.67
EBDIT Annual Margin % 11.71 7.32 17.46 23.83 26.47
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
Krishna Datla 34.01 75061450 0 0
Satish Varma Azad Nadimpally 11.73 75061451 0 0
Anupama Datla Desai 8.7 75061452 0 0
Preeti Thakkar 7.61 75061454 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
Rakesh Kantilal Shah 3.47 75061464
Kunal Ashok Kashyap 2.08 75061465
Rajeshwari Datla 2.02 75061466
Krishan Premnarayen 1.38 75061467
HUF 0.72 75061458
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 22, 2023 1.25 FINAL Sep 22, 2023 Equity Share
Aug 04, 2022 1.25 FINAL Aug 05, 2022 Equity Share
Aug 25, 2021 2.5 FINAL - Equity Share
Nov 22, 2019 5 INTERIM Nov 25, 2019 Equity Share
Jun 28, 2019 1.25 FINAL - Equity Share
Sep 19, 2018 1.25 FINAL - Equity Share
Sep 21, 2017 2.5 FINAL - Equity Share
Sep 19, 2016 2.5 FINAL - Equity Share
Sep 22, 2015 5 FINAL - Equity Share
Sep 10, 2014 2.5 FINAL - Equity Share
Feb 24, 2014 7.5 INTERIM Feb 25, 2014 Equity Share
Sep 13, 2012 15 FINAL - Equity Share
Jul 05, 2012 15 INTERIM Jul 06, 2012 Equity Share
Feb 23, 2012 15 INTERIM Feb 24, 2012 Equity Share
Sep 15, 2011 10 FINAL - Equity Share
Feb 22, 2011 15 INTERIM Feb 23, 2011 Equity Share
Sep 15, 2010 7.5 FINAL - Equity Share
Jun 03, 2010 7.5 INTERIM Jun 04, 2010 Equity Share
Sep 17, 2009 7.5 FINAL - Equity Share
Jun 29, 2009 7.5 INTERIM Jun 30, 2009 Equity Share
Sep 18, 2008 10 FINAL - Equity Share
Sep 06, 2007 5 FINAL - Equity Share
Sep 21, 2006 2.5 FINAL - Equity Share
Sep 08, 2005 2.5 FINAL - Equity Share
Aug 30, 2004 6 FINAL - Equity Share
Sep 17, 2003 6 FINAL - Equity Share
Sep 13, 2002 2.5 FINAL - Equity Share
Feb 20, 2002 3.5 INTERIM Mar 04, 2002 Equity Share
Nov 05, 2001 2.5 FINAL - Equity Share
Ex-Date Split Ratio Record Date
Aug 08, 2018 10:5 2018-08-09
Ex-Date Purpose Notes
May 27, 2024 Audited Results & Final Dividend -
Feb 12, 2024 Quarterly Results -
Nov 08, 2023 Quarterly Results -
Aug 11, 2023 Quarterly Results -
May 29, 2023 Audited Results & Final Dividend -
Feb 10, 2023 Quarterly Results -
Nov 11, 2022 Quarterly Results -
Aug 12, 2022 Quarterly Results -
May 30, 2022 Audited Results, Dividend & A.G.M. -
Feb 14, 2022 Quarterly Results -
Nov 12, 2021 Quarterly Results -
Oct 11, 2021 Scheme of Arrangement -
Aug 13, 2021 Quarterly Results -
Jun 29, 2021 Audited Results & Final Dividend -
Feb 11, 2021 Quarterly Results -
Nov 09, 2020 Quarterly Results -
Sep 14, 2020 Quarterly Results -
Aug 28, 2020 Final Dividend & A.G.M. -
Jun 29, 2020 Audited Results & Final Dividend -
Feb 12, 2020 Quarterly Results -
Dec 24, 2019 Bonus issue & ESOP -
Nov 13, 2019 Quarterly Results -
Aug 05, 2019 Quarterly Results -
May 24, 2019 Audited Results & Final Dividend -
Feb 12, 2019 Quarterly Results -
Nov 13, 2018 Quarterly Results -
Aug 14, 2018 Unaudited Financial Results & A.G.M. -
Jun 21, 2018 Others Approved the Scheme of Amalgamation ('Scheme') under Sections 230-232 and other applicable provisions of the Companies Act, 2013 between the Company and its subsidiary company, Fermenta Biotech Ltd.
Jun 18, 2018 Bonus issue & Stock Split -
May 15, 2018 Audited Results & Final Dividend -
Feb 06, 2018 Quarterly Results -
Dec 14, 2017 Quarterly Results -
Sep 14, 2017 Quarterly Results -
May 30, 2017 Audited Results & Final Dividend -
Feb 13, 2017 Quarterly Results -
Nov 14, 2016 Quarterly Results -
Aug 12, 2016 Quarterly Results -
May 27, 2016 Audited Results & Dividend -
Feb 11, 2016 Quarterly Results -
Nov 09, 2015 Quarterly Results -
Aug 14, 2015 Quarterly Results -
May 29, 2015 Audited Results & Final Dividend -
Feb 13, 2015 Quarterly Results -
Nov 14, 2014 Quarterly Results -
Aug 12, 2014 Quarterly Results -
May 30, 2014 Audited Results & Final Dividend -
Feb 13, 2014 Quarterly Results -
Nov 14, 2013 Quarterly Results -
Aug 14, 2013 Quarterly Results -
May 29, 2013 Audited Results & Final Dividend -
Feb 13, 2013 Quarterly Results -
Nov 10, 2012 Quarterly Results -
Aug 14, 2012 Quarterly Results -
Jun 26, 2012 Interim Dividend -
May 29, 2012 Audited Results & Final Dividend -
Feb 13, 2012 Quarterly Results -
Nov 14, 2011 Quarterly Results -
Aug 10, 2011 Quarterly Results -
May 28, 2011 Audited Results & Final Dividend -
Feb 11, 2011 Quarterly Results -
Nov 12, 2010 Quarterly Results -
Aug 13, 2010 Quarterly Results -
May 22, 2010 Audited Results -
Jan 29, 2010 Quarterly Results -
Oct 29, 2009 Quarterly Results -
Aug 06, 2009 Others The Board approved the execution of a Share Purchase and a Shareholders Agreement primarily between DIL Ltd & Evotec AG concerning transfer of 2,54,94,000 equity shares.
Jul 30, 2009 Quarterly Results -
Jun 18, 2009 Audited Results & Dividend -
Jan 28, 2009 Quarterly Results -
Oct 25, 2008 Quarterly Results -
Jul 29, 2008 Quarterly Results -
Jun 20, 2008 Audited Results & Dividend -
Jan 22, 2008 Quarterly Results -
Oct 30, 2007 Quarterly Results -
Jul 28, 2007 Quarterly Results -
Jun 29, 2007 Audited Results & Dividend -
Feb 21, 2007 Amalgamation of its 100% subsidiary Amalgamation of its 100% subsidiary, White Stripes Entertainment Ltd with the Company.
Feb 05, 2007 Scheme of Arrangement Amalgamation of one of its wholly owned subsidiary Company will be merged with the Company.
Jan 26, 2007 Quarterly Results -
Oct 27, 2006 Quarterly Results -
Jul 29, 2006 Quarterly Results -
Jun 09, 2006 Accounts & Dividend -
Jan 25, 2006 Quarterly Results -
Oct 27, 2005 Quarterly Results -
Jul 21, 2005 Quarterly Results -
Apr 25, 2005 Dividend & Accounts -
Mar 17, 2005 Buy Back of equity shares To consider the following: 1. Proposal for purchase of Company's own equity shares under applicable laws pertaining to Buy Back of equity shares; 2. Proposal to shift the Registered Office of the Co.
Jan 29, 2005 Quarterly Results -
Oct 27, 2004 Quarterly Results -
Jul 29, 2004 Quarterly Results -
Jun 28, 2004 Dividend & Accounts -
Mar 09, 2004 General 1) setting up a joint venture company in the Czech Republic for manufacturing and marketing of Wheel Chairs. 2) setting up a media and entertainment company.
Jan 30, 2004 Quarterly Results -
Oct 29, 2003 Quarterly Results -
Sep 01, 2003 Others Allotment of Shares or warrants on Preferential basis
Aug 25, 2003 Quarterly Results -
Jul 29, 2003 Quarterly Results -
Apr 30, 2003 Quarterly Results (Revised)
Jan 29, 2003 Quarterly Results -
Oct 31, 2002 Quarterly Results -
Jul 31, 2002 Accounts, Dividend & Quarterly Results -
Apr 30, 2002 Quarterly Results -
Mar 07, 2002 Interim Dividend (2nd Interim) (Revised)
Jan 30, 2002 Quarterly Results & Others Quarterly Results & Interim Dividend & Restructuring of the Board
Oct 31, 2001 Half Yearly Results & Quarterly Results -
Oct 16, 2001 Accounts & Dividend -
Jul 31, 2001 Quarterly Results (Revised)
May 03, 2001 Others Demerger of Pharmaceutical business of the company and to fix the Record Date for issue of shares of Duphar Pharma India Ltd., to the shareholders of the company.
Apr 30, 2001 Quarterly Results -
Jan 30, 2001 Quarterly Results -
Oct 30, 2000 Quarterly Results -
Jul 29, 2000 Quarterly Results, Dividend & Accounts -
Apr 29, 2000 Quarterly Results -
Jan 31, 2000 Quarterly Results -
Oct 30, 1999 Quarterly Results -
Jul 31, 1999 Quarterly Results -
Apr 27, 1999 Quarterly Results -
Jan 29, 1999 Quarterly Results -
Oct 29, 1998 Quarterly Results -
Nov 27, 1997 Half Yearly Results -
Jun 30, 1997 Accounts & Dividend -
Ex-Date Bonus Ratio Record Date
Feb 13, 2020 2:1 2020-02-14
Aug 08, 2018 1:1 2018-08-09
Bigul
06 Jul 2024

Fermenta Biotech Ltd - 506414 - Successful Closure Of US FDA Inspection At Company''s Facility

 US FDA has issued an Establishment Inspection Report with no observations for Company''s facility at Dahej, Gujarat, India.
Bigul
01 Jul 2024

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Bigul
28 Jun 2024

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Closure of trading window from July 1, 2024.
Bigul
20 Jun 2024

Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

 Post Ballot result, regulation 44, scrutinizer report
Bigul
20 Jun 2024

Fermenta Biotech Ltd - 506414 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 Post Ballot results, regulation 44 results, scrutinizers report
Bigul
12 Jun 2024

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Corrigendum - Intimation of Earnings Presentation for Quarter 4 of Financial year 2023-24 and FY 2023-24.
Bigul
11 Jun 2024

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Intimation of Earnings presentation for Quarter 4 FY 2023-24 and FY 2023-24
Bigul
10 Jun 2024

Fermenta Biotech Ltd - 506414 - Update On The Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015

 Update on the Development Agreement for development of the Company''s Land at Thane
Bigul
31 May 2024

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation under regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015
Bigul
30 May 2024

Fermenta Biotech Ltd - 506414 - Clarification On Record Date

 Clarification on record date for the purpose of 72nd Annual General Meeting and payment of Dividend
See all News

FAQs

The latest market price of Fermenta Biotech Ltd. on NSE was Rs. 206.30 as of today.

The opening share price of Fermenta Biotech Ltd. was Rs. 190.90 as of today.

The 52-week high share price of Fermenta Biotech Ltd. was Rs. 219.00.

The 52 week low share price of Fermenta Biotech Ltd. was Rs. 133.00.

Please find Corporate actions section for more details.

The PE ratio of Fermenta Biotech Ltd. is -0.50. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Fermenta Biotech Ltd. was on 2023-09-22 for Rs. 1.25 per share. According to today’s share price, the dividend yield of Fermenta Biotech Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Fermenta Biotech Ltd. was as of 2020-02-13. The bonus ratio declared in this issue was 2:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Fermenta Biotech Ltd. was as of 2018-08-08. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Fermenta Biotech Ltd..

Close

Let's Open Free Demat Account